AUTHOR=Araújo Jessica Alves de Medeiros , Hilscher Markus M. , Marques-Coelho Diego , Golbert Daiane C. F. , Cornelio Deborah A. , Batistuzzo de Medeiros Silvia R. , Leão Richardson N. , Costa Marcos R. 

TITLE=Direct Reprogramming of Adult Human Somatic Stem Cells Into Functional Neurons Using Sox2, Ascl1, and Neurog2

JOURNAL=Frontiers in Cellular Neuroscience

VOLUME=12

YEAR=2018

URL=https://www.frontiersin.org/journals/cellular-neuroscience/articles/10.3389/fncel.2018.00155

DOI=10.3389/fncel.2018.00155

ISSN=1662-5102

ABSTRACT=<p>Reprogramming of somatic cells into induced pluripotent stem cells (iPS) or directly into cells from a different lineage, including neurons, has revolutionized research in regenerative medicine in recent years. Mesenchymal stem cells are good candidates for lineage reprogramming and autologous transplantation, since they can be easily isolated from accessible sources in adult humans, such as bone marrow and dental tissues. Here, we demonstrate that expression of the transcription factors (TFs) SRY (sex determining region Y)-box 2 (<italic>Sox2</italic>), Mammalian achaete-scute homolog 1 (<italic>Ascl1</italic>), or Neurogenin 2 (<italic>Neurog2</italic>) is sufficient for reprogramming human umbilical cord mesenchymal stem cells (hUCMSC) into induced neurons (iNs). Furthermore, the combination of <italic>Sox2/Ascl1</italic> or <italic>Sox2/Neurog2</italic> is sufficient to reprogram up to 50% of transfected hUCMSCs into iNs showing electrical properties of mature neurons and establishing synaptic contacts with co-culture primary neurons. Finally, we show evidence supporting the notion that different combinations of TFs (<italic>Sox2/Ascl1</italic> and <italic>Sox2/Neurog2</italic>) may induce multiple and overlapping neuronal phenotypes in lineage-reprogrammed iNs, suggesting that neuronal fate is determined by a combination of signals involving the TFs used for reprogramming but also the internal state of the converted cell. Altogether, the data presented here contribute to the advancement of techniques aiming at obtaining specific neuronal phenotypes from lineage-converted human somatic cells to treat neurological disorders.</p>